High throughput analysis of alendronate in human samples with derivatization-free hydrophilic-interactive chromatography mass spectrometry.


Journal

Journal of pharmaceutical and biomedical analysis
ISSN: 1873-264X
Titre abrégé: J Pharm Biomed Anal
Pays: England
ID NLM: 8309336

Informations de publication

Date de publication:
05 Jan 2024
Historique:
received: 17 08 2023
revised: 06 10 2023
accepted: 08 10 2023
medline: 3 11 2023
pubmed: 16 10 2023
entrez: 15 10 2023
Statut: ppublish

Résumé

A derivatization-free hydrophilic-interactive chromatography-mass spectrometry (HILIC-MS/MS) method was developed for quantifying low levels of alendronate in human plasma. Alendronate was separated and concentrated using calcium co-precipitation and analyzed by HILIC-MS/MS, requiring only a 300 μL plasma sample for each analysis. The method is simpler, safer, and more environmentally friendly than the conventional LC-MS/MS method that requires solid-phase extraction and derivatization steps during sample pretreatment. The method was validated for selectivity, linearity, precision, accuracy, extraction recovery, matrix effect and limit of quantification. The between-run precisions were no more than 7.1 % with accuracy ranging from - 1.7-6.3 %; extraction recovery was determined to be 85.3 %; while validation results indicated that the method was suitable for accurately quantifying alendronate concentrations in the range from 0.2 to 50 ng/mL. The approach was used successfully for high throughput analysis of alendronate in more than 3700 plasma samples from 120 subjects in a bioequivalence study.

Identifiants

pubmed: 37839263
pii: S0731-7085(23)00544-7
doi: 10.1016/j.jpba.2023.115775
pii:
doi:

Substances chimiques

Alendronate X1J18R4W8P

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115775

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Yi-Fan Shieh (YF)

NOVOTECH laboratory Taiwan, Taipei, Taiwan.

Fu-Mei Hung (FM)

NOVOTECH laboratory Taiwan, Taipei, Taiwan.

Szu-Ning Yeh (SN)

NOVOTECH laboratory Taiwan, Taipei, Taiwan.

Li-Ting Kao (LT)

NOVOTECH laboratory Taiwan, Taipei, Taiwan.

Jen-Chi Chen (JC)

NOVOTECH laboratory Taiwan, Taipei, Taiwan.

Fu-En Liao (FE)

NOVOTECH laboratory Taiwan, Taipei, Taiwan.

Jenpang Huang (J)

MSonline Scientific Corporation, Taipei, Taiwan.

Chin-Hsiung Wang (CH)

MSonline Scientific Corporation, Taipei, Taiwan. Electronic address: seanwang8888@gmail.com.

Chi-Yang Lee (CY)

Department of Chemistry, National Sun Yat-Sen University, Kaohsiung, Taiwan.

Jentaie Shiea (J)

Department of Chemistry, National Sun Yat-Sen University, Kaohsiung, Taiwan; Rapid Screening Research Center for Toxicology and Biomedicine, National Sun Yat-Sen University, Kaohsiung, Taiwan; Department of Medical Chemistry, Kaohsiung Medical University, Kaohsiung, Taiwan. Electronic address: jetea@mail.nsysu.edu.tw.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH